GGrantIndex
← Leaderboards

Central Arkansas Veterans Hlthcare Sys

North Little Rock, AR

Compare ↔
$0
Total funding
56
Grants

Funding over time

peak $0 · FY200925
$1$1$1$0$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

VA$0 · 56

By mechanism

I01$0 · 34
I21$0 · 8
I50$0 · 6
IK2$0 · 2
IK6$0 · 5
IP1$0 · 1

Investigators at Central Arkansas Veterans Hlthcare Sys

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Largest grants

RANKL and Inflammation-associated Bone Loss$0
I01 · FY2011 · VA
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2011 · VA
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2012 · VA
Role of serine protease KLK7 in pancreatic cancer$0
I01 · FY2012 · VA
Estrogens, androgens, aging, and bone loss in males$0
I01 · FY2013 · VA
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2009 · VA
An exercise and nutritional intervention for deconditioned older adults.$0
I01 · FY2014 · VA
Mechanisms of cLDL-Induced Endothelial Injury$0
I01 · FY2014 · VA
Get Moving and Get Well: A Behavioral Activation Program for Veterans with SMI$0
I21 · FY2014 · VA
Analysis and Therapy of Age-Dependent Proteostasis Failure in Neurodegeneration$0
I01 · FY2014 · VA
Evaluation of the National Implementation of the VA Diffusion of Excellence Initiative on Advanced Care Planning with Group Visits$0
I50 · FY2021 · VA
Implementing Caring Contacts for Suicide Prevention in Non-Mental Health Settings$0
I50 · FY2021 · VA
Behavioral Health QUERI Implementation Facilitation Training Hub$0
I50 · FY2021 · VA
Role of Natural Antibodies Against Oxidation Specific Epitopes in Bone Homeostasis$0
I01 · FY2022 · VA
Mechanisms of cLDL-Induced Endothelial Injury$0
I01 · FY2013 · VA
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis$0
I01 · FY2022 · VA
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment$0
I01 · FY2022 · VA
Development and Validation of a Perceived Access Measure$0
I01 · FY2014 · VA
Glucocorticoid-induced osteonecrosis of the hip, osteocytes and canalicular fluid$0
I01 · FY2015 · VA
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.$0
I01 · FY2014 · VA